[Women's hearts are hard to break. Coronary heart diseases--is the woman a special case!?].
1. Recommendations and decisions concerning treatment should primarily be based on the absolute evaluation of risk and risk reduction and not on calculation of a relative risk situation. 2. The therapeutic benefit in women at low risk should be balanced against possible physical and psychic side effects and submitted to a cost/benefit analysis. 3. The fact that coronary heart disease is rare in young women must not at all be reason for a less consequent treatment and prevention in women with established coronary heart disease.
Newnham
H H
HH
Oberärztin, Medizinische Poliklinik, Departement für Innere Medizin, Rämistrasse, Zürich.
Silberberg
J
J
D000368:Aged; D003327:Coronary Disease / Q000209:etiology / Q000401:mortality* / Q000517:prevention & control; D003362:Cost-Benefit Analysis; D015914:Estrogen Replacement Therapy / Q000191:economics; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000191:economics; D008875:Middle Aged; D012307:Risk Factors; D013557:Switzerland / Q000453:epidemiology